Delegation of powers under Rule 122 L of the Drugs & Cosmectics Rules
Delegation of powers under Rule 122 L of the Drugs & Cosmectics Rules
Delegation of powers under Rule 122 L of the Drugs & Cosmectics Rules Read More »
Delegation of powers under Rule 122 L of the Drugs & Cosmectics Rules
Delegation of powers under Rule 122 L of the Drugs & Cosmectics Rules Read More »
DCGI directs drugs manufacturers to file safety & efficacy data on non-approved FDC formulation before 31st August 2013
Clarification regarding continued availability of Gatifloxacin opthalmic formulations
Clarification regarding continued availability of Gatifloxacin opthalmic formulations Read More »
Banned Drugs Gazette Notification 18 June 2013 on Pioglitazone and all formulations containing Pioglitazone for human use
Banned Drugs Gazette Notification 18 June 2013 on Flupenthixol + Melitracem
Banned Drugs Gazette Notification 18 June 2013 on Flupenthixol + Melitracem Read More »
Banned Drugs Gazette Notification 18 June 2013 on Analgin and all formulations containing Analgin for human use
Ban of two drugs Gatifloxacin and Tegaserod and its formulations
Ban of two drugs Gatifloxacin and Tegaserod and its formulations Read More »
Amendment of the Drugs and Cosmectics Rules relating to prohibition of testing of cosmetics on animals-regarding
Amendment of Rules relating to loan licensing system under the Drugs and Cosmetics Rules, 1945, for introduction of loan licensing system for drugs covered under CLAA scheme vide GSR 574(E) dated 17.07.2012-extracts of the rule amended
Limiting of Acetaminophen (Paracetamol) in Prescription Combination Products ans giving Box Warning About its Liver Toxicity.